uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted January 12, 2021

FDA Warns Seller of Joint and Hair Loss Products

On December 22, 2020, the FDA issued a warning letter to Speedwinds Nutrition, Inc. following a review of the company's website, which found statements made about the company's products Synotrex and Sephren to be drug claims.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at